阿尔法-曼戈斯的降脂效应:在高脂血症动物模型中的系统审查和元分析
Moragot Chatatikun1,2, Aman Tedasen1,2, Phichayut Phinyo3,4
1Department of Medical Technology, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80160, Thailand.
Foods (Basel, Switzerland)
|June 13, 2025
概括
在动物模型中,阿尔法-曼戈斯 (AM) 有效地降低了有害的脂质,如甘油三,总胆固醇和LDL胆固醇,同时提高了有益的HDL胆固醇. 这种天然化合物显示出作为降脂剂的前景.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
- 代谢疾病 代谢疾病
背景情况:
- 超脂血是心血管和代谢疾病的重要危险因素.
- 药理治疗高脂血症有潜在的不良影响.
- 目前正在探索用于脂质管理的天然替代品.
研究的目的:
- 在超脂血症动物模型中系统地审查和元分析α-曼戈斯 (AM) 的降脂效应.
- 评估AM在脂质资料上的整体疗效.
- 为了确定影响AM疗效的因素.
主要方法:
- 按照PRISMA 2020指南进行系统审查和元分析.
- 搜索了Scopus,PubMed,ScienceDirect,Cochrane图书馆和科学网进行受控研究.
- 包括9项与226只动物的研究,评估甘油三 (TG),总胆固醇 (TC),LDL-C和HDL-C.
- 使用Cochrane RoB 2工具评估的偏差风险.
主要成果:
- 分析显示,AM显著降低了TG,TC和LDL-C.
- AM显著增加了HDL-C.
- 较低剂量 (<50 mg/kg/day) 显示出更强的降脂效应.
- 亚组分析表明物种,地区和治疗持续时间的影响.
结论:
- 阿尔法-曼戈斯 (AM) 在临床前动物模型中显示出显著的降脂潜力.
- AM有效调节关键的脂质参数,表明治疗有前途.
- 需要进一步的临床研究来确认人类的疗效和最佳剂量.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...